{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibfvrrnhwzullqadxkyowndkvuis7upy5y4pkoxx2jarfmhx2egzm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnnq4pom52w2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaw5vdrtqyme5lshc7izzldp3purcqlk44gt4zo5pidyo26xw6s4e"
    },
    "mimeType": "image/jpeg",
    "size": 118436
  },
  "path": "/news/2026-06-drug-survival-advanced-pancreatic-cancer.html",
  "publishedAt": "2026-06-06T18:30:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.",
  "title": "Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease"
}